Login to Your Account



Early Stage Deals Still Wow? Innate Jumps on BMS Alliance

By Jennifer Boggs


Wednesday, July 13, 2011
During the recent BIO International Convention in Washington, panelists in a business development session discussed whether biotech firms can count on scoring major dollars by licensing early stage – preclinical or Phase I – programs. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription